← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-06-25

Drug application

FDA Application #

ANDA213414

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

DAPSONE

Active ingredients

DAPSONE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2026-06-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown